About
Copy Link
Titles
Research Associate 1 MS
Departments & Organizations
- All Institutions
Research
Copy Link
Research at a Glance
Yale Co-Authors
Frequent collaborators of Maria Figetakis's published research.
Publications Timeline
A big-picture view of Maria Figetakis's research output by year.
Kaelyn Sumigray, PhD
Richard Torres, MD, MS, BS
William Chang, MD, PhD
5Publications
11Citations
Publications
2025
Nkx2-3 defines the splenic vascular patterning in a lineage-and-dose-dependent manner 9187
Balogh P, Balogh P, Váradi K, Berta G, Heidt D, Figetakis M, Sumigray K, Kellermayer Z. Nkx2-3 defines the splenic vascular patterning in a lineage-and-dose-dependent manner 9187. The Journal Of Immunology 2025, 214 DOI: 10.1093/jimmun/vkaf283.2624.Peer-Reviewed Original ResearchConceptsLineage-restricted expressionLYVE-1Vascular patternMarginal sinusImpaired humoral immune responseRed pulpGene dosageSplenic vasculatureLymphatic capillariesVE-cadherin-CreMarginal reticular cellsHumoral immune responsePeripheral maintenanceExpression of Nkx2KO miceEctopic inductionLymphocyte differentiationSplenic structureEndothelial venulesImmune responseMAdCAM-1Lymphatic vesselsNKX2Lymphatic circulationMice
2024
A Coculture System for Modeling Intestinal Epithelial-Fibroblast Crosstalk
Lee R, Li M, Figetakis M, Sumigray K. A Coculture System for Modeling Intestinal Epithelial-Fibroblast Crosstalk. Methods In Molecular Biology 2024, 2951: 19-34. PMID: 38700834, PMCID: PMC11938088, DOI: 10.1007/7651_2024_544.Peer-Reviewed Original ResearchCitationsAltmetric
2021
A therapeutic vascular conduit to support in vivo cell-secreted therapy
Han EX, Qian H, Jiang B, Figetakis M, Kosyakova N, Tellides G, Niklason LE, Chang WG. A therapeutic vascular conduit to support in vivo cell-secreted therapy. Npj Regenerative Medicine 2021, 6: 40. PMID: 34326344, PMCID: PMC8322381, DOI: 10.1038/s41536-021-00150-2.Peer-Reviewed Original ResearchCitationsAltmetricConceptsEnd-stage renal diseaseVascular conduitsLong-term efficacyVascular graftsHemoglobin levelsRenal diseaseCell-based therapiesMacrophage infiltrationCell transplantationHemodialysis accessAcellular vesselsLuminal obstructionSerum erythropoietinNude ratsClinical disordersCellular implantationEPO expressionErythropoietinGraftTherapyAdequate vascularizationBiological effectsHuman Amniotic Membrane as a Novel Scaffold for Inducible Pluripotent Stem Cell-derived Kidney Organoids
Figetakis M, James KJ, Kosyakova N, Torres R, Chang WG. Human Amniotic Membrane as a Novel Scaffold for Inducible Pluripotent Stem Cell-derived Kidney Organoids. ASAIO Journal 2021, 68: e73-e76. PMID: 35503644, PMCID: PMC9065564, DOI: 10.1097/mat.0000000000001476.Peer-Reviewed Original ResearchCitationsAltmetric
2020
Human Amniotic Membrane as a Novel Scaffold for Induced Pluripotent Stem Cell-Derived Kidney Organoids
Figetakis M, James K, Torres R, Chang W. Human Amniotic Membrane as a Novel Scaffold for Induced Pluripotent Stem Cell-Derived Kidney Organoids. Journal Of The American Society Of Nephrology 2020, 31: 145-145. DOI: 10.1681/asn.20203110s1145a.Peer-Reviewed Original Research
Academic Achievements & Community Involvement
Copy Link
Get In Touch
Copy Link